Literature DB >> 25590787

Tuning Salmonella for cancer therapy.

Hak-Sung Kim1, Jung Min Choi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25590787      PMCID： PMC4612456          DOI： 10.1080/15384101.2015.1006561

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  5 in total

1.  Efficacy against lung metastasis with a tumor-targeting mutant of Salmonella typhimurium in immunocompetent mice.

Authors:  Ming Zhao; Atsushi Suetsugu; Huaiyu Ma; Lei Zhang; Fang Liu; Yong Zhang; Benjamin Tran; Robert M Hoffman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

2.  Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer.

Authors:  Vu H Nguyen; Hyung-Seok Kim; Jung-Min Ha; Yeongjin Hong; Hyon E Choy; Jung-Joon Min
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

Review 3.  Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy.

Authors:  Paulina Chorobik; Janusz Marcinkiewicz
Journal:  Pol Arch Med Wewn       Date:  2011-12

Review 4.  Engineering the perfect (bacterial) cancer therapy.

Authors:  Neil S Forbes
Journal:  Nat Rev Cancer       Date:  2010-10-14       Impact factor: 60.716

5.  Targeted deletion of the ara operon of Salmonella typhimurium enhances L-arabinose accumulation and drives PBAD-promoted expression of anti-cancer toxins and imaging agents.

Authors:  Hyun Hong; Daejin Lim; Geun-Joong Kim; Seung-Hwan Park; Hyeon Sik Kim; Yeongjin Hong; Hyon E Choy; Jung-Joon Min
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.